Tejara Capital LTD Trevi Therapeutics, Inc. Transaction History
Tejara Capital LTD
- $153 Billion
- Q4 2024
A detailed history of Tejara Capital LTD transactions in Trevi Therapeutics, Inc. stock. As of the latest transaction made, Tejara Capital LTD holds 153,739 shares of TRVI stock, worth $694,900. This represents 0.41% of its overall portfolio holdings.
Number of Shares
153,739
Previous 241,613
36.37%
Holding current value
$694,900
Previous $807 Million
21.51%
% of portfolio
0.41%
Previous 0.38%
Shares
8 transactions
Others Institutions Holding TRVI
# of Institutions
114Shares Held
77.6MCall Options Held
218KPut Options Held
182K-
Nea Management Company, LLC Timonium, MD11.4MShares$51.4 Million3.46% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA10.7MShares$48.2 Million2.72% of portfolio
-
Viking Global Investors LP4.4MShares$19.9 Million0.06% of portfolio
-
Rubric Capital Management LP New York, NY4.21MShares$19 Million0.3% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct4.15MShares$18.8 Million0.04% of portfolio
About Trevi Therapeutics, Inc.
- Ticker TRVI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 58,322,500
- Market Cap $264M
- Description
- Trevi Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of Haduvio to treat serious neurologically mediated conditions. The company is developing Haduvio, an oral extended-release formulation of nalbuphine, which is in phase IIb/III clinical trial for the treatment of chronic pruritu...